Cited 51 times in
Robot-assisted thoracoscopic esophagectomy with extensive mediastinal lymphadenectomy: experience with 114 consecutive patients with intrathoracic esophageal cancer.
DC Field | Value | Language |
---|---|---|
dc.contributor.author | 김대준 | - |
dc.date.accessioned | 2017-02-27T07:58:12Z | - |
dc.date.available | 2017-02-27T07:58:12Z | - |
dc.date.issued | 2016 | - |
dc.identifier.issn | 1120-8694 | - |
dc.identifier.uri | https://ir.ymlib.yonsei.ac.kr/handle/22282913/147044 | - |
dc.description.abstract | The study aims to report the operative outcomes of robot-assisted thoracoscopic esophagectomy (RATE) with extensive mediastinal lymphadenectomy (ML) for intrathoracic esophageal cancer. We analyzed a prospective database of 114 consecutive patients who underwent RATE with lymph node dissection along recurrent laryngeal nerve (RLN) followed by cervical esophagogastrostomy. The study included 104 men with a mean age of 63.1 ± 0.8 years. Of these, 110 (96.5%) had squamous cell carcinoma, and the location of the tumor was upper esophagus in 7 (6.1%), middle in 62 (54.4%), and lower in 45 (39.5%). Preoperative concurrent chemoradiation was performed in 15 patients (13.2%). All but one patient underwent successful RATE, and R0 resection was achieved in 111 patients (97.4%). Extended ML and total ML were performed in 24 (21.1%) and 90 (78.9%) patients, respectively. Total operation time was 419.6 ± 7.9 minutes, and robot console time was 206.6 ± 5.2 minutes. The mean number of total, mediastinal, and RLN nodes was 43.5 ± 1.4, 24.5 ± 1.0, and 9.7 ± 0.7, respectively. The most common complication was RLN palsy (30, 26.3%), followed by anastomotic leakage (17, 14.9%) and pulmonary complications (11, 9.6%). Median hospital stay was 16 days, and 90-day mortality was observed in three patients (2.5%). On multivariate analysis, preoperative concurrent chemoradiation was a risk factor for pulmonary complications (odds ratio 7.42, 95% confidence interval 1.91-28.8, P = 0.004). RATE with extensive ML could be performed safely with acceptable postoperative outcomes. Long-term survival data should be followed in the future to verify the oncological outcome of the procedure. | - |
dc.description.statementOfResponsibility | restriction | - |
dc.format.extent | 326~332 | - |
dc.language | English | - |
dc.publisher | Wiley-Blackwell | - |
dc.relation.isPartOf | DISEASES OF THE ESOPHAGUS | - |
dc.rights | CC BY-NC-ND 2.0 KR | - |
dc.rights.uri | https://creativecommons.org/licenses/by-nc-nd/2.0/kr/ | - |
dc.subject.MESH | Carcinoma, Squamous Cell/mortality | - |
dc.subject.MESH | Carcinoma, Squamous Cell/pathology | - |
dc.subject.MESH | Carcinoma, Squamous Cell/surgery | - |
dc.subject.MESH | Esophageal Neoplasms*/mortality | - |
dc.subject.MESH | Esophageal Neoplasms*/pathology | - |
dc.subject.MESH | Esophageal Neoplasms*/surgery | - |
dc.subject.MESH | Esophagectomy*/adverse effects | - |
dc.subject.MESH | Esophagectomy*/methods | - |
dc.subject.MESH | Female | - |
dc.subject.MESH | Humans | - |
dc.subject.MESH | Lymph Node Excision*/adverse effects | - |
dc.subject.MESH | Lymph Node Excision*/methods | - |
dc.subject.MESH | Lymph Nodes*/pathology | - |
dc.subject.MESH | Lymph Nodes*/surgery | - |
dc.subject.MESH | Lymphatic Metastasis | - |
dc.subject.MESH | Male | - |
dc.subject.MESH | Mediastinum | - |
dc.subject.MESH | Middle Aged | - |
dc.subject.MESH | Operative Time | - |
dc.subject.MESH | Outcome and Process Assessment (Health Care) | - |
dc.subject.MESH | Postoperative Complications/diagnosis | - |
dc.subject.MESH | Postoperative Complications/epidemiology | - |
dc.subject.MESH | Republic of Korea/epidemiology | - |
dc.subject.MESH | Risk Factors | - |
dc.subject.MESH | Robotic Surgical Procedures*/adverse effects | - |
dc.subject.MESH | Robotic Surgical Procedures*/methods | - |
dc.subject.MESH | Thoracoscopy*/adverse effects | - |
dc.subject.MESH | Thoracoscopy*/methods | - |
dc.title | Robot-assisted thoracoscopic esophagectomy with extensive mediastinal lymphadenectomy: experience with 114 consecutive patients with intrathoracic esophageal cancer. | - |
dc.type | Article | - |
dc.publisher.location | United States | - |
dc.contributor.college | College of Medicine | - |
dc.contributor.department | Dept. of Thoracic & Cardiovascular Surgery | - |
dc.contributor.googleauthor | S. Y. Park | - |
dc.contributor.googleauthor | D. J. Kim | - |
dc.contributor.googleauthor | W. S. Yu | - |
dc.contributor.googleauthor | H. S. Jung | - |
dc.identifier.doi | 10.1111/dote.12335 | - |
dc.contributor.localId | A00368 | - |
dc.relation.journalcode | J00745 | - |
dc.identifier.eissn | 1442-2050 | - |
dc.identifier.pmid | 25716873 | - |
dc.identifier.url | http://onlinelibrary.wiley.com/doi/10.1111/dote.12335/abstract | - |
dc.subject.keyword | esophageal cancer | - |
dc.subject.keyword | outcome | - |
dc.subject.keyword | robotic surgery | - |
dc.contributor.alternativeName | Kim, Dae Joon | - |
dc.contributor.affiliatedAuthor | Kim, Dae Joon | - |
dc.citation.volume | 29 | - |
dc.citation.number | 4 | - |
dc.citation.startPage | 326 | - |
dc.citation.endPage | 332 | - |
dc.identifier.bibliographicCitation | DISEASES OF THE ESOPHAGUS, Vol.29(4) : 326-332, 2016 | - |
dc.date.modified | 2017-02-24 | - |
dc.identifier.rimsid | 47076 | - |
dc.type.rims | ART | - |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.